AGR2 and neoplasm: Interestingly, extracellular AGR2 is not only clinically relevant in human tumors, but also significantly correlated with malignant mammary tumor (MMT) progression (P = 0.0007), distant tumor metastasis (P = 0.002) and poor overall survival (P = 0.0158) in dogs (83).